Table 2

Summary of findings

MethodMeasureCORTReelinKetamine
BehaviorFST immobility
FST swimming
FST climbing
FST latency to immobility
SPT habituation
SPT test
ElectrophysiologyI/O curve
PTP
LTP
ImmunohistochemistryReelin
Western blottingp-mTOR↔ (WH and SNP)↔ (WH and SNP)↑ (WH) ↔ (SNP)
mTOR↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
p-GluA1↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
GluA1↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
p-CREB↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
CREB↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
Synapsin I↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
PSD-95↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
GluN2b↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
p-Erk1/2↔ (WH and SNP)↔ (WH and SNP)↔ (WH and SNP)
  • CORT, corticosterone; CREB, cAMP response element-binding protein; Erk1/2, extracellular signal-regulated kinase; FST, forced swim test; I/O, input/output; LTP, long-term potentiation; mTOR, mechanistic target of rapamycin; p-, phosphorylated-; PSD-95, postsynaptic density-95; PTP, post-tetanic potentiation; SPT, sucrose preference test; SNP, synaptoneurosome; WH, whole homogenate. ↑, increased; ↓, decreased; ↔, unchanged.